Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-κB and JNK/AP1 pathways

Oncogene volume 22, pages 3371–3385 (2003)Cite this article

Abstract

The Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a FADD-like interferon converting enzyme or caspase 8 (FLICE) inhibitory protein (vFLIP) that prevents death receptor-mediated apoptosis by inhibiting the recruitment and activation of FLICE. Since vFLIP physically interacts with tumor necrosis factor receptor associated factor 2 (TRAF2) and TRAF2 mediates activation of the jun NH2-terminal kinase (JNK)/activation protein 1 (AP1) pathway, we hypothesized that vFLIP might also activate this pathway. To evaluate this hypothesis, we transiently and stably transfected a vFLIP expression construct and performed several complementary assays to document that vFLIP activates the JNK/AP1 pathway and does so in a TRAF-dependent fashion. As vFLIP also activates the nuclear factor κB (NF-κB) signaling pathway and the NF-κB and JNK/AP1 pathways both modulate cellular interleukin-6 (cIL-6) expression, we postulated that vFLIP induces expression of this cytokine. We show that vFLIP induces cIL-6 expression and activates the cIL-6 promoter, and maximal activation of the cIL-6 promoter by vFLIP requires NF-κB and AP1 activation. In addition, vFLIP and latency-associated nuclear antigen (LANA), another KSHV-encoded latent protein, potentiate each other's ability to activate the cIL-6 promoter. Gene silencing experiments by RNA interference demonstrate that vFLIP in BCBL-1 endogenously infected primary effusion lymphoma (PEL) cells mediates JNK/AP1 activation and cIL-6 expression. Thus, we conclude that vFLIP, in addition to its known effects on NF-κB activation, also modulates the JNK/AP1 pathway and induces gene expression from the cIL-6 promoter in a JNK/AP1-dependent fashion.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

References

  • An J, Lichtenstein AK, Brent G and Rettig MB . (2002). Blood, 99, 649–654.

  • Asou H, Said JW, Yang R, Munker R, Park DJ, Kamada N and Koeffler HP . (1998). Blood, 91, 2475–2481.

  • Baud V, Liu ZG, Bennett B, Suzuki N, Xia Y and Karin M . (1999). Genes Dev., 13, 1297–1308.

  • Black EJ, Street AJ and Gillespie DA . (1991). Oncogene, 6, 1949–1958.

  • Butterfield L, Storey B, Maas L and Heasley LE . (1997). J. Biol. Chem., 272, 10110–10116.

  • Cesarman E, Chang Y, Moore PS, Said JW and Knowles DM . (1995). N. Engl. J. Med., 332, 1186–1191.

  • Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM and Moore PS . (1994). Science, 266, 1865–1869.

  • Chaudhary PM, Jasmin A, Eby MT and Hood L . (1999). Oncogene, 18, 5738–5746.

  • Dadgostar H and Cheng G . (1998). J. Biol. Chem., 273, 24775–24780.

  • Dendorfer U, Oettgen P and Libermann TA . (1994). Mol. Cell. Biol., 14, 4443–4454.

  • Diaz BV, Lenoir MC, Ladoux A, Frelin C, Demarchez M and Michel S . (2000). J. Biol. Chem., 275, 642–650.

  • Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A and Ganem D . (1998). J. Virol., 72, 8309–8315.

  • Djerbi M. Screpanti V, Catrina AI, Bogen B, Biberfeld P and Grandien A . (1999). J. Exp. Med., 190, 1025–1032.

  • Ensoli B, Nakamura S, Salahuddin SZ, Biberfeld P, Larsson L, Beaver B, Wong-Staal F and Gallo RC . (1989). Science, 243, 223–226.

  • Foreman KE, Friborg J, Kong WP, Woffendin C, Polverini PJ . Nickoloff BJ and Nabel GJ . (1997). N. Engl. J. Med., 336, 163–171.

  • Foussat A, Wijdenes J, Bouchet L, Gaidano G, Neipel F, Balabanian K, Galanaud P, Couderc J and Emilie D . (1999). Eur. Cytokine Netw., 10, 501–508.

  • Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, Saah A, Phair J, Detels R, Parry P, Chang Y and Moore PS . (1996). N. Engl. J. Med., 335, 233–241.

  • Glykofrydes D, Niphuis H, Kuhn EM, Rosenwirth B, Heeney JL, Bruder J, Niedobitek G, Muller-Fleckenstein I, Fleckenstein B and Ensser A . (2000). J. Virol., 74, 11919–11927.

  • Grandadam M, Dupin N, Calvez V, Gorin I, Blum L, Kernbaum S, Sicard D, Buisson Y, Agut H, Escande JP and Huraux JM . (1997). J. Infect. Dis., 175, 1198–1201.

  • Grundhoff A and Ganem D . (2001). J. Virol., 75, 1857–1863.

  • Hu S, Vincenz C, Buller M and Dixit VM . (1997). J. Biol. Chem., 272, 9621–9624.

  • Karin M . (1994). Curr. Opin. Cell Biol., 6, 415–424.

  • Keller SA, Schattner EJ and Cesarman E . (2000). Blood, 96, 2537–2542.

  • Lee HH, Dadgostar H, Cheng Q, Shu J and Cheng G . (1999). Proc. Natl. Acad. Sci. USA, 96, 9136–9141.

  • Leger-Ravet MB, Peuchmaur M, Devergne O, Audouin J. Raphael M, Van Damme J, Galanaud P, Diebold J and Emilie D . (1991). Blood, 78, 2923–2930.

  • Libermann TA and Baltimore D . (1990). Mol. Cell. Biol., 10, 2327–2334.

  • Liu B and Shuai K . (2001). J. Biol. Chem., 276, 36624–36631.

  • Low W, Harries M, Ye H, Du MQ, Boshoff C and Collins M . (2001). J. Virol., 75, 2938–2945.

  • Miles SA, Rezai AR, Salazar-Gonzalez JF, Vander MM . Stevens RH, Logan DM, Mitsuyasu RT, Taga T, Hirano T, Kishimoto T and Martinez-Maza O . (1990). Proc. Natl. Acad. Sci. USA, 87, 4068–4072.

  • Moore PS and Chang Y . (1995). N. Engl. J. Med., 332, 1181–1185.

  • Panyutich EA, Said JW and Miles SA . (1998). AIDS, 12, 467–472.

  • Radkov SA, Kellam P and Boshoff C . (2000). Nat. Med., 6, 1121–1127.

  • Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H, Herrington CS, Moore PS and Schulz TF . (1997). J. Virol., 71, 5915–5921.

  • Raitano AB, Halpern JR, Hambuch TM, and Sawyers CL . (1995). Proc. Natl. Acad. Sci. USA, 92, 11746–11750.

  • Ray A, Ratter SB, May LT and Sehgal PB . (1988). Proc. Natl. Acad. Sci. USA, 85, 6701–6705.

  • Reinhard C, Shamoon B, Shyamala V and Williams LT . (1997). EMBO J., 16, 1080–1092.

  • Sarid R, Flore O, Bohenzky RA, Chang Y and Moore PS . (1998). J. Virol., 72, 1005–1012.

  • Sarid R, Wiezorek JS, Moore PS and Chang Y . (1999). J. Virol., 73, 1438–1446.

  • Screpanti I, Musiani P, Bellavia D, Cappelletti M, Aiello FB. Maroder M, Frati L, Modesti A, Gulino A and Poli V . (1996). J. Exp. Med., 184, 1561–1566.

  • Siegmund D, Mauri D, Peters N, Juo P, Thome M, Reichwein M, Blenis J, Scheurich P, Tschopp J and Wajant H . (2001). J. Biol. Chem., 276, 32585–32590.

  • Smeal T, Binetruy B, Mercola D, Grover-Bardwick A, Heidecker G, Rapp UR and Karin M . (1992). Mol. Cell. Biol., 12, 3507–3513.

  • Smeal T, Binetruy B, Mercola DA, Birrer M and Karin M . (1991). Nature, 354, 494–496.

  • Song HY, Regnier CH, Kirschning CJ, Goeddel DV and Rothe M . (1997). Proc. Natl. Acad. Sci. USA, 94, 9792–9796.

  • Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay MF, Clauvel JP, Raphael M and Degos L . (1995). Blood, 86, 1276–1280.

  • Talbot SJ, Weiss RA, Kellam P and Boshoff C . (1999). Virology, 257, 84–94.

  • Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME and Tschopp J . (1997). Nature, 386, 517–521.

Download references

Acknowledgements

We thank Drs Alan K Lichtenstein and Gregory Brent for their critical review of the manuscript and helpful discussions. Supported by research funds of the Veterans Administration, including a Career Development Award and the VA Research Enhancement Award Program (REAP) (both to MBR), the Jonsson Comprehensive Cancer Center at UCLA (to MBR and RS), the American Cancer Society (Grant # RPG-00-305-01-MBC to MBR), the Public Health Service (Grant # 1R01CA80004-01A1 to MBR), and the American Society of Hematology (Junior Faculty Scholar Award to MBR).

Author information

Authors and Affiliations

  1. Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, 90073, CA, USA

    Jiabin An, Yiping Sun & Matthew B Rettig

  2. Department of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, 90095, CA, USA

    Ren Sun

  3. Department of Medicine, UCLA School of Medicine, Los Angeles, 90095, CA, USA

    Matthew B Rettig

Authors
  1. Jiabin An
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yiping Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ren Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matthew B Rettig
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew B Rettig.

Rights and permissions

Reprints and permissions

About this article

Cite this article

An, J., Sun, Y., Sun, R. et al. Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-κB and JNK/AP1 pathways. Oncogene 22, 3371–3385 (2003). https://doi.org/10.1038/sj.onc.1206407

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206407

Keywords

This article is cited by

Search

Advanced search

Quick links